| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 01/09/2008 | CN100360519C Benzothiepine ileal bile acid transport inhibitors |
| 01/09/2008 | CN100360500C N,N'-biacetylcysteine-diarginine salt isomer and its uses |
| 01/09/2008 | CN100360177C Medicine for treating fungal dermatitis |
| 01/09/2008 | CN100360173C Lyase treatment for p. carinii |
| 01/09/2008 | CN100360142C Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 01/09/2008 | CN100360134C Injection liquid containing alprostadic and its production process |
| 01/09/2008 | CN100360132C Combination of medication for antivirus in use for eye region and preparation method |
| 01/09/2008 | CN100360131C Production method of odor-masking enrofloxacin |
| 01/09/2008 | CN100360122C Preventive and/or therapeutic agent for viral infection |
| 01/09/2008 | CN100360115C Molecular coating method of plant polyphenol kind substance |
| 01/09/2008 | CN100360016C Foot disinfectant |
| 01/08/2008 | US7317101 Antibacterial cephalosporins |
| 01/08/2008 | US7317089 Immunmoglobulin specific to tumor necrosis factor (ligand) superfamily, member 13b (tnfsf13b) protein for use in treatment and prevention of autoimmune, inflammatory, respiratory system, skin , blood and cell proliferative disorders |
| 01/08/2008 | US7317077 Neural thread proteins (NTP); antiproliferative agents |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317009 Pyrrolopyridazine derivatives |
| 01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 01/08/2008 | US7316813 Influenza vaccine composition |
| 01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/08/2008 | CA2388716C Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
| 01/08/2008 | CA2348474C Pharmaceutically active composition and dispensing device |
| 01/08/2008 | CA2337885C Enteric coated pharmaceutical tablet and method of manufacturing |
| 01/08/2008 | CA2192433C Anti-herpesvirus compounds and methods for identyfying, making and using same |
| 01/08/2008 | CA2181164C Anti-gram-positive bacterial methods and materials |
| 01/08/2008 | CA2145826C Lipopeptide derivatives, a process for their preparation and their use |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/04/2008 | CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/03/2008 | WO2008002924A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |
| 01/03/2008 | WO2008001878A1 Hydroxy ether compound, process for production of the compound, and use of the compound |
| 01/03/2008 | WO2008001849A1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 01/03/2008 | WO2008001498A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 01/03/2008 | WO2008001212A2 Penem prodrugs |
| 01/03/2008 | WO2008001134A1 1,2,3,8,9,9a-hexahydro-7h-benzo(de)-1,7-naphthyridin-7-one derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 01/03/2008 | WO2008000920A1 D-glucopyranose 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxybenzoate] compound and its derivatives, preparation thereof and uses thereof |
| 01/03/2008 | WO2008000881A1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 01/03/2008 | WO2008000454A2 Composition for the treatment of skin comprising ink sack liquid of cephalopods |
| 01/03/2008 | WO2008000166A1 Granule and preparation method thereof |
| 01/03/2008 | WO2007126900A3 Antifungal agents |
| 01/03/2008 | WO2007107696A3 Pharmaceutically acceptable salts and polymorphic forms |
| 01/03/2008 | WO2007103565A3 Wnv dna vaccine incorporating a cmv/r backbone and expressing wnv prm and e proteins |
| 01/03/2008 | WO2007099409A3 Therapeutic compositions containing trimethoprim and cranberry extract and methods for treating and preventing urinary tract infections |
| 01/03/2008 | WO2007096703A3 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 01/03/2008 | WO2007082922A8 Long term treatment of hiv- infection with tcm278 |
| 01/03/2008 | WO2007066201A3 Chemical compounds |
| 01/03/2008 | WO2007049155A3 Compositions comprising yersinia pestis antigens |
| 01/03/2008 | WO2006113942A3 Method of inhibiting cathepsin activity |
| 01/03/2008 | WO2006035066A8 Toll-like receptor 3, its signalling associated molecule trif and their use in the prevention and treatment of host inflammation response induced by a rna virus |
| 01/03/2008 | US20080004297 Compounds and therapeutical use thereof |
| 01/03/2008 | US20080004277 Triazole compounds that modulate HSP90 activity |
| 01/03/2008 | US20080004275 Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds |
| 01/03/2008 | US20080004270 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors |
| 01/03/2008 | US20080004265 HIV Integrase Inhibitors |
| 01/03/2008 | US20080004242 Process for preparation of HIV protease inhibitors |
| 01/03/2008 | US20080004217 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome (hadds) with or without lipodystrophy |
| 01/03/2008 | US20080003682 treatment or prevention of infection through the expression of one or more RNA molecules that inhibit one or more aspects of the life cycle of a pathogen through RNA interference with a target nucleic acid; for human lymphadenopathy associated viral diseases |
| 01/03/2008 | US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
| 01/03/2008 | US20080003658 Method for expression of small antiviral rna molecules within a cell |
| 01/03/2008 | US20080003636 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent |
| 01/03/2008 | US20080003294 Methods for pulmonary delivery of interleukin-2 |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003250 Novel therapy for herpesvirus infection |
| 01/03/2008 | US20080003240 Contacting sample of cell that contains exogenous FGFR3 where contacted cell is capable of BoNT/A intoxication and detecting presence of BoNT/A activity of cell relative to control cell, where difference in BoNT/A activity of contacted cell compared to control cell is indicative of BoNT/A activity |
| 01/03/2008 | US20080003234 Secreted campylobacter flagella coregulated proteins as immunogens |
| 01/03/2008 | US20080003232 Cpg Single Strand Deoxynucleotides for Use as Adjuvant |
| 01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
| 01/03/2008 | US20080003201 Interleukin-12 as a veterinary vaccine adjuvant |
| 01/03/2008 | US20080003190 Antibacterial botanicals |
| 01/03/2008 | US20080003183 Nanoparticle radiosensitizers |
| 01/03/2008 | DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it |
| 01/03/2008 | DE102006030164A1 Inhalative Pulver Inhalation powder |
| 01/03/2008 | DE102006030073A1 Lipstick, useful for the treatment of herpes, protection of lip from sunburn and for lip care |
| 01/03/2008 | DE102006030031A1 Feminine hygiene article, useful for the prevention and fight against candidiasis, comprises vitamin B12, vitamin B12 synthesis promoting substances, folic acid, vitamin B6, zinc oxides, cobalt, dimethylbenzimidazole and biotin |
| 01/03/2008 | CA2656604A1 Injectable formulation of antibiotic and solution for intravenous administration thereof |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2654414A1 Granule and preparation method thereof |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873155A1 Inhibitors of the HIV integrase enzyme |
| 01/02/2008 | EP1872793A1 Polyamino acid for use as adjuvant |
| 01/02/2008 | EP1872791A1 Use of bacterial polysaccharides for biofilm inhibition |
| 01/02/2008 | EP1872780A2 Omega-Phenyloctanamides as therapeutic compounds |
| 01/02/2008 | EP1871786A1 Peptide vaccine for influenza virus |
| 01/02/2008 | EP1871777A1 (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors |
| 01/02/2008 | EP1871766A1 Antifungal triazole derivatives |
| 01/02/2008 | EP1871742A1 Preparation of ý2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)¨pyrrole derivatives |
| 01/02/2008 | EP1871400A2 Uronic acid and probiotics |
| 01/02/2008 | EP1871395A1 Garlic extract and chitosan compositions, and uses thereof |
| 01/02/2008 | EP1871365A2 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/02/2008 | EP1871349A1 Quaternary ammonium halides for treatment of infectious conditions |
| 01/02/2008 | EP1871181A2 Nutritional supplement for hiv patients |
| 01/02/2008 | EP1750700B1 Liquid preparation for veterinary medicine, method for the production thereof, and use of the same |
| 01/02/2008 | EP1623028B1 Crystal structure of human coronavirus 229e main proteinase, and uses thereof for developing sars inhibitors |
| 01/02/2008 | EP1474422B1 R-(-)-1-¬2-(7-CHLOROBENZO-¬B -THIOPHEN-3-Yl-METHOXY)-2-(2,4-DICHLOROPHENYL)ETHYL -1H-IMIDAZOLE |
| 01/02/2008 | EP1472344B1 Bacteriophage lysin |
| 01/02/2008 | EP1448223B1 Thymosin augmentation of genetic immunization |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1278868B1 Mutated form of arginine deiminase |